Bayer Surges In Europe After Appeals Court Win In Roundup Cancer Case
Bayer AG Wins US Court Ruling on Cancer Lawsuit Landmark Decision Could Impact Future Cases Bayer AG (OTCMKTS: BAYRY) saw its shares soar by up to 12% on Friday following a favorable court ruling in the US. The decision, made by a Philadelphia appeals court, could have significant implications for Bayer and other companies facing similar litigation. The lawsuit in question alleges that Bayer's Roundup weedkiller contains glyphosate, a chemical linked to cancer. Bayer has maintained that Roundup is safe and has vigorously defended itself against the claims. The appeals court's ruling overturned a lower court decision that had allowed the case to proceed. The court found that the plaintiffs had failed to provide sufficient evidence to support their claims. This ruling is a major victory for Bayer and could set the stage for future dismissals of similar lawsuits. Key Points: * Bayer AG won a significant legal victory in a long-running cancer litigation case. * The rul...